Ningbo Menovo Pharmaceutical Co., Ltd.

Researches, produces and sells specialty active ingredients and intermediates, with a CDMO platform and finished-product subsidiaries. Its products include valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium and pregabalin, across cardiovascular, neurological and gastrointestinal areas. Its Tiankang subsidiary reports capacity of 1.5 billion tablets and capsules a year.